Norges Bank’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.2M Buy
+3,947,387
New +$55.2M 0.01% 912
2025
Q1
Sell
-1,065,608
Closed -$21.7M 483
2024
Q4
$21.7M Buy
+1,065,608
New +$21.7M ﹤0.01% 1217
2024
Q3
Sell
-823,941
Closed -$19.1M 496
2024
Q2
$19.1M Sell
823,941
-411,825
-33% -$9.56M ﹤0.01% 1227
2024
Q1
$25.4M Buy
1,235,766
+83,120
+7% +$1.71M ﹤0.01% 1200
2023
Q4
$24.7M Buy
1,152,646
+348,754
+43% +$7.48M ﹤0.01% 1207
2023
Q3
$16.6M Buy
803,892
+223,558
+39% +$4.61M ﹤0.01% 1292
2023
Q2
$17.1M Sell
580,334
-389,106
-40% -$11.5M ﹤0.01% 1320
2023
Q1
$22.3M Sell
969,440
-54,766
-5% -$1.26M ﹤0.01% 1240
2022
Q4
$28.5M Buy
1,024,206
+80,802
+9% +$2.25M 0.01% 1107
2022
Q3
$29M Buy
943,404
+111,595
+13% +$3.42M 0.01% 1026
2022
Q2
$24.5M Sell
831,809
-14,254
-2% -$419K 0.01% 1145
2022
Q1
$27.2M Sell
846,063
-46
-0% -$1.48K 0.01% 1224
2021
Q4
$37.7M Sell
846,109
-7,247
-0.8% -$323K 0.01% 1102
2021
Q3
$43.1M Buy
853,356
+111,376
+15% +$5.62M 0.01% 998
2021
Q2
$58.2M Buy
741,980
+144,214
+24% +$11.3M 0.01% 883
2021
Q1
$34.1M Sell
597,766
-258,663
-30% -$14.8M 0.01% 1199
2020
Q4
$71.7M Sell
856,429
-49,944
-6% -$4.18M 0.02% 750
2020
Q3
$32.5M Sell
906,373
-26,206
-3% -$939K 0.01% 1107
2020
Q2
$22.6M Sell
932,579
-15,959
-2% -$386K 0.01% 1358
2020
Q1
$16.6M Buy
948,538
+325,000
+52% +$5.69M 0.01% 1371
2019
Q4
$10.9M Hold
623,538
﹤0.01% 1775
2019
Q3
$9.55M Buy
623,538
+48,076
+8% +$737K ﹤0.01% 1791
2019
Q2
$11.9M Hold
575,462
﹤0.01% 1742
2019
Q1
$13.4M Buy
+575,462
New +$13.4M ﹤0.01% 1695
2018
Q2
Sell
-265,616
Closed -$5.23M 2139
2018
Q1
$5.23M Sell
265,616
-384,384
-59% -$7.57M ﹤0.01% 1888
2017
Q4
$10.2M Buy
+650,000
New +$10.2M ﹤0.01% 1735